ATG5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.288200E-01
Normal-vs-Stage2
5.851200E-01
Normal-vs-Stage3
1.824750E-01
Normal-vs-Stage4
9.293400E-01
Stage1-vs-Stage2
8.212200E-01
Stage1-vs-Stage3
4.881800E-01
Stage1-vs-Stage4
5.553800E-01
Stage2-vs-Stage3
1.887410E-01
Stage2-vs-Stage4
4.700600E-01
Stage3-vs-Stage4
1.571550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.687000E-01
Normal-vs-AfricanAmerican
8.152000E-01
Normal-vs-Asian
6.016000E-01
Caucasian-vs-AfricanAmerican
2.939000E-01
Caucasian-vs-Asian
7.170200E-01
AfricanAmerican-vs-Asian
3.779600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.744400E-01
Normal-vs-Female
6.096400E-01
Male-vs-Female
7.788800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.233200E-01
Normal-vs-Age(41-60Yrs)
9.413200E-01
Normal-vs-Age(61-80Yrs)
4.122600E-01
Normal-vs-Age(81-100Yrs)
8.242200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.009200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.291600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.016800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.239000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.350800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.182800E-01
Normal-vs-Daily Drinker
2.080800E-01
Normal-vs-Weekly Drinker
4.953400E-01
Normal-vs-Occasional Drinker
6.759000E-01
Normal-vs-Social Drinker
8.268800E-01
Non Drinker-vs-Daily Drinker
4.252000E-01
Non Drinker-vs-Weekly Drinker
9.213600E-01
Non Drinker-vs-Occasional Drinker
3.274600E-01
Non Drinker-vs-Social Drinker
3.146000E-01
Daily Drinker-vs-Weekly Drinker
4.561000E-01
Daily Drinker-vs-Occasional Drinker
8.037700E-02
Daily Drinker-vs-Social Drinker
1.053400E-01
Weekly Drinker-vs-Occasional Drinker
4.696400E-01
Weekly Drinker-vs-Social Drinker
4.627200E-01
Occasional Drinker-vs-Social Drinker
8.616200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.480400E-01
Normal-vs-Grade 2
6.027400E-01
Normal-vs-Grade 3
5.746800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.775600E-01
Grade 1-vs-Grade 3
2.762800E-01
Grade 1-vs-Grade 4
2.480400E-01
Grade 2-vs-Grade 3
4.747400E-01
Grade 2-vs-Grade 4
6.027400E-01
Grade 3-vs-Grade 4
5.746800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.856200E-01
Normal-vs-NonDiabetic
5.501800E-01
Diabetic-vs-NonDiabetic
2.154800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.246600E-01
Normal-vs-NoPancreatitis
4.870600E-01
Pancreatitis-vs-NoPancreatitis
7.788000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.317400E-01
Normal-vs-N1
5.986600E-01
N0-vs-N1
9.392000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.820400E-01
Normal-vs-TP53-NonMutant
7.718000E-01
TP53-Mutant-vs-TP53-NonMutant
2.806000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
